ORY.MC BME
Oryzon Genomics S.A.
1W: +0.0%
1M: -2.9%
3M: -7.8%
YTD: -13.1%
1Y: +2.2%
3Y: +33.2%
5Y: -15.7%
€2.73 ($3.07)
-0.02 (-0.80%)
Weekly Expected Move ±2.5%
€3
€3
€3
€3
€3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$145M
+32.9% ▲
5Y CAGR: +9.0%
Total Liabilities
$27M
+23.1% ▲
5Y CAGR: +8.0%
Shareholders Equity
$105M
+21.1% ▲
5Y CAGR: +6.8%
Cash & Investments
$28M
+404.9% ▲
5Y CAGR: -6.5%
Total Debt
$12M
-26.4% ▼
5Y CAGR: -2.5%
Net Debt
-$16M
-254.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $29M | $21M | $12M | $6M | $28M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $15K |
| Cash & ST Investments | $29M | $21M | $12M | $6M | $28M |
| Net Receivables | $1M | $1M | $647K | $1M | $2M |
| Inventory | $104K | $10K | $6K | $3K | $4K |
| Other Current Assets | $2M | $3M | $1M | $2M | $0 |
| Total Current Assets | $33M | $25M | $14M | $9M | $31M |
| Property, Plant & Equip. | $682K | $611K | $481K | $356K | $380K |
| Goodwill & Intangibles | $60M | $76M | $381K | $97M | $109M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $126K |
| Other Non-Current Assets | $29K | $31K | $90M | $3M | $0 |
| Total Non-Current Assets | $63M | $79M | $93M | $100M | $114M |
| Total Assets | $95M | $104M | $107M | $109M | $145M |
| — Liabilities — | |||||
| Accounts Payable | $3M | $5M | $3M | $2M | $3M |
| Short-Term Debt | $4M | $10M | $10M | $9M | $5M |
| Deferred Revenue | $0 | $3M | $0 | $0 | $0 |
| Other Current Liabilities | $351K | -$673K | $2M | $50K | $7M |
| Total Current Liabilities | $9M | $19M | $16M | $12M | $16M |
| Long-Term Debt | $13M | $7M | $3M | $7M | $7M |
| Other Non-Current Liab. | $2M | $3M | $3M | $2M | $20K |
| Total Non-Current Liabilities | $15M | $12M | $9M | $10M | $11M |
| Total Liabilities | $24M | $31M | $25M | $22M | $27M |
| — Equity — | |||||
| Common Stock | $3M | $3M | $3M | $3M | $4M |
| Retained Earnings | -$8M | -$12M | -$16M | -$19M | -$21M |
| Accumulated OCI | $3M | $3M | $0 | $4M | -$4M |
| Total Stockholders Equity | $71M | $73M | $82M | $87M | $105M |
| Total Liabilities & Equity | $95M | $104M | $107M | $109M | $145M |
| — Key Metrics — | |||||
| Total Debt | $18M | $17M | $14M | $16M | $12M |
| Net Debt | -$15M | -$4M | $1M | $11M | -$16M |
| Total Investments | $0 | $0 | $0 | $0 | $140K |